v3.26.1
Acquisitions - Schedule Of Preliminary Allocation Of The Purchase Price (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Jul. 08, 2025
Dec. 31, 2024
ASSETS        
Goodwill $ 26,710 $ 26,376   $ 0
Akoya Biosciences, Inc.        
ASSETS        
Cash and cash equivalents     $ 16,108  
Accounts receivable, net of allowance for expected credit losses     8,616  
Inventory     25,493  
Prepaid expenses and other assets     5,441  
Property and equipment, net     12,087  
Intangible assets     121,800  
Goodwill     26,710  
Operating lease right-of-use assets     4,585  
Finance lease right-of-use assets     1,041  
Total assets acquired     221,881  
Liabilities:        
Accounts payable     8,266  
Accrued expenses and other liabilities     37,107  
Deferred revenue     18,879  
Operating lease liabilities     5,616  
Finance lease liabilities     1,040  
Total liabilities assumed     70,908  
Net assets acquired     $ 150,973